McMillan Shakespeare Ltd (ASX: MMS) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

McMillan Shakespeare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $1.22 billion
P/E Ratio 12.76
Dividend Yield 8.48%
Shares Outstanding 69.64 million
Earnings per share 1.368
Dividend per share 1.54
Year To Date Return 2.40%
Earnings Yield 7.83%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • McMillan Shakespeare Ltd (ASX: MMS)
    Latest News

    a woman
    ⏸️ Investing

    Why the Emerchants Ltd share price surged higher today

    Emerchants Ltd (ASX:EML) shares have jumped higher after a major agreement with McMillan Shakespeare Limited (ASX:MMS). Is this exciting fintech…

    Read more »

    a woman
    ⏸️ Investing

    Here's why these 4 ASX shares are soaring today

    BT Investment Management Ltd (ASX:BTT) is one of four shares helping to take the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) higher. Here’s…

    Read more »

    a woman
    ⏸️ Investing

    2 under-the-radar dividend stars for your shopping list

    McMillan Shakespeare Limited (ASX:MMS) and Automotive Holdings Group Ltd (ASX:AHG) have solid track records of paying dividends to shareholders.

    Read more »

    a woman
    ⏸️ Investing

    Which is the best salary packaging stock to buy today? (Part II)

    A close look at McMillan Shakespeare Limited (ASX:MMS), Smartgroup Corporation Ltd (ASX:SIQ) and SG Fleet Group Ltd (ASX:SGF).

    Read more »

    a woman
    ⏸️ Investing

    Which is the best salary packaging stock to buy today? (Part I)

    A close look at McMillan Shakespeare Limited (ASX:MMS), Smartgroup Corporation Ltd (ASX:SIQ) and SG Fleet Group Ltd (ASX:SGF).

    Read more »

    a woman
    ⏸️ Investing

    3 companies which doubled their dividends in the last 5 years

    Insurance Australia Group Ltd (ASX:IAG), McMillan Shakespeare Limited (ASX:MMS) and Macquarie Group Ltd (ASX:MQG) have more than doubled their dividends…

    Read more »

    a woman
    ⏸️ Investing

    Why the Lovisa Holdings Ltd share price soared today

    Lovisa Holdings Ltd (ASX:LOV) share prices soars more than 14%

    Read more »

    a woman
    ⏸️ Investing

    3 shares set to raise their dividends in FY 2017

    McMillan Shakespeare Limited (ASX:MMS), iSentia Group Ltd (ASX:ISD) and QBE Insurance Group Ltd (ASX:QBE) could be attractive to income investors…

    Read more »

    a woman
    ⏸️ Investing

    3 ASX shares near 52-week highs with room to run harder

    Westfield Corp Ltd (ASX:WFD) McMillan Shakespeare Limited (ASX:MMS) and Challenger Ltd (ASX:CGF) have recently hit 52-week highs but they look…

    Read more »

    a woman
    ⏸️ Investing

    Why these 4 shares are climbing higher today

    Crown Resorts Ltd (ASX:CWN) and Super Retail Group Ltd (ASX:SUL) are just two of the shares outperforming the market today.

    Read more »

    a woman
    ⏸️ Investing

    Here's how Bill Shorten just sent these ASX shares rocketing

    McMillan Shakespeare Limited (ASX:MMS) has rocketed on news that a Shorten government wouldn’t make any changes to salary packaging and…

    Read more »

    a woman
    ⏸️ Investing

    Fairfax Media Limited & McMillan Shakespeare Limited: 2 shares that could rebound higher

    Fairfax Media Limited (ASX:FXJ) and McMillan Shakespeare Limited (ASX:MMS) had a great March, but will it be the same story…

    Read more »

    Frequently Asked Questions

    Yes, McMillan Shakespeare historically pays two fully franked dividends a year.

    McMillan Shakespeare generally pays its shareholder dividends in March and September.

    McMillan Shakespeare Ltd was listed on the ASX on 15 March 2004.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    11 Sep 2025 $0.7700 100.00% Final 26 Sep 2025
    13 Mar 2025 $0.7100 100.00% Interim 28 Mar 2025
    12 Sep 2024 $0.7800 100.00% Final 27 Sep 2024
    07 Mar 2024 $0.7600 100.00% Interim 22 Mar 2024
    07 Sep 2023 $0.6600 100.00% Final 22 Sep 2023
    09 Mar 2023 $0.5800 100.00% Final 24 Mar 2023
    26 Oct 2022 $0.7400 100.00% Final 10 Nov 2022
    10 Mar 2022 $0.3400 100.00% Interim 25 Mar 2022
    09 Sep 2021 $0.3110 100.00% Final 24 Sep 2021
    11 Mar 2021 $0.3020 100.00% Interim 26 Mar 2021
    05 Mar 2020 $0.3400 100.00% Interim 20 Mar 2020
    28 Aug 2019 $0.4000 100.00% Final 11 Sep 2019
    07 Mar 2019 $0.3400 100.00% Interim 22 Mar 2019
    13 Sep 2018 $0.4000 100.00% Final 28 Sep 2018
    15 Mar 2018 $0.3300 100.00% Interim 29 Mar 2018
    28 Sep 2017 $0.0000 100.00% Final 13 Oct 2017
    30 Mar 2017 $0.3100 100.00% Interim 13 Apr 2017
    29 Sep 2016 $0.3400 100.00% Final 14 Oct 2016
    31 Mar 2016 $0.2900 100.00% Interim 15 Apr 2016
    16 Sep 2010 $0.1400 100.00% Final 15 Oct 2010
    08 Mar 2006 $0.0250 100.00% Interim 29 Mar 2006
    18 Aug 2005 $0.0240 100.00% Final 16 Sep 2005

    MMS ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About McMillan Shakespeare Ltd

    McMillan Shakespeare Ltd (ASX: MMS) is an employee benefits provider. Its services include salary packaging, novated leasing, disability plan management and support coordination, asset management, and related financial products and services.

    The company's asset management businesses provide motor vehicle leasing and fleet management services, as well as fleet and consumer financing.

    McMillan Shakespeare consists of more than 20 subsidiaries, the majority incorporated in Australia but also in New Zealand and the United Kingdom.

    MMS Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    13 Jan 2026 $17.49 $0.00 0.00% 109,154 $17.70 $17.70 $17.46
    12 Jan 2026 $17.49 $0.03 0.17% 103,798 $17.51 $17.80 $17.40
    09 Jan 2026 $17.46 $0.12 0.69% 81,429 $17.40 $17.59 $17.38
    08 Jan 2026 $17.34 $0.13 0.76% 68,884 $17.24 $17.34 $17.12
    07 Jan 2026 $17.21 $0.11 0.64% 89,773 $17.15 $17.34 $17.05
    06 Jan 2026 $17.10 $0.19 1.12% 103,644 $17.05 $17.23 $16.93
    05 Jan 2026 $16.91 $-0.25 -1.46% 120,681 $17.20 $17.34 $16.86
    02 Jan 2026 $17.16 $0.11 0.65% 60,183 $17.08 $17.29 $17.04
    31 Dec 2025 $17.05 $0.14 0.83% 79,887 $16.92 $17.18 $16.92
    30 Dec 2025 $16.91 $0.04 0.24% 91,572 $16.95 $17.05 $16.81
    29 Dec 2025 $16.87 $0.00 0.00% 75,025 $16.88 $17.01 $16.80
    24 Dec 2025 $16.87 $-0.23 -1.35% 36,340 $17.16 $17.21 $16.87
    23 Dec 2025 $17.10 $0.07 0.41% 115,736 $17.19 $17.23 $16.93
    22 Dec 2025 $17.03 $0.21 1.25% 97,721 $16.90 $17.04 $16.70
    19 Dec 2025 $16.82 $0.10 0.60% 255,037 $16.74 $16.83 $16.65
    18 Dec 2025 $16.72 $0.27 1.64% 66,388 $16.51 $16.78 $16.41
    17 Dec 2025 $16.45 $-0.03 -0.18% 72,614 $16.40 $16.58 $16.23
    16 Dec 2025 $16.48 $0.12 0.73% 134,388 $16.35 $16.51 $16.20

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    05 Dec 2025 Robert (Rob) De Luca Issued 55,123 $951,422
    Director remuneration. 1,51,977 Rights
    16 Sep 2025 Robert (Rob) De Luca Issued 91,232 $1,560,979
    Conversion of securities.
    16 Sep 2025 Robert (Rob) De Luca Exercise 91,232 $1,560,979
    Conversion of securities. 99,583 Rights
    16 Sep 2025 Robert (Rob) De Luca Transfer 8,668 $148,309
    Off-market transfer. Assuming off market transfer of shares
    16 Sep 2025 Robert (Rob) De Luca Transfer 8,668 $148,309
    Off-market transfer. Assuming off market transfer of shares
    16 Sep 2025 Robert (Rob) De Luca Expiry 2,729 $46,693
    As advised by the company. Expired
    12 Sep 2025 Robert (Rob) De Luca Issued 5,884 $104,441
    Director remuneration. 1,90,815 Rights

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Bruce John Akhurst Non-Executive Director Apr 2021
    Mr Akhurst is currently the Chair of the Peter McCallum Cancer Foundation. He was previously the Chairman and Director of Tabcorp Holdings Limited, CEO of Sensis, Group MD and General Counsel of Telstra, Partner of Mallesons Stephen Jaques, Council Member of RMIT University and a Director of Vocus Group Limited. He is a member of Member of Risk and Compliance Committee.
    Mr John G Bennetts Non-Executive Director Dec 2003
    Mr Bennetts is an experienced investor and has been the founder and director of several successful Australian companies. He owns businesses in varied industries including technology and finance. He is a Non-Executive Director of Sacred Heart Mission. He was a founder of Cellestis Limited and private equity investment firm, Mooroolbark Investments Pty Limited (M-Group). He has also provided corporate advisory services to a range of companies in Australia and Asia.
    Mr Ross Chessari Non-Executive Director Dec 2003
    Mr Chessari is a founder and director of the investment manager, SciVentures Investments Pty Limited (SciVentures). Prior to founding SciVentures, he was the Managing Director of ANZ Asset Management and the General Manager of ANZ Trustees.
    Ms Helen Kurincic Non-Executive DirectorNon-Executive Chairman Sep 2018
    Ms Kurincic is a Non-Executive Director of Ramsay Health Care Limited and Carlton Football Club Limited. She has formerly held Board roles across the publicly listed, private, not-for profit and government sectors including Non-Executive Chair of Integral Diagnostics Limited, Non-Executive Director of Estia Health Limited, insurer HBF Health Limited, Domain Principal Group, DCA Group and Melbourne Health. She is a member of Member of Risk and Compliance Committee and People and Culture Committee.
    Ms Arlene May Tansey Non-Executive Director Nov 2022
    Ms Tansey is a Non-Executive Director of Aristocrat Leisure Limited and La Trobe Financial (including La Trobe Private Credit Fund). She is also a Board member of the Australian National Maritime Museum and University of Wollongong Global Enterprises. She is a former Nonexecutive Director of TPG Telecom, Lendlease Investment Management, WiseTech Global Limited, Infrastructure NSW and the Australian Institute of Company Directors (NSW Division Council). She is Member of the Risk and Compliance Committee and Member of the People Culture Committee.
    Mr Robert (Rob) De Luca Chief Executive OfficerManaging Director May 2022
    Mr De Luca joined MMS in May 2022 and has over 20 years' experience in the Financial Services, Wealth Management, Disability and Healthcare sectors, including roles as Managing Director of Bankwest, and CEO of the National Disability Insurance Agency (NDIA). Prior to joining MMS, he was CEO of Zenitas Healthcare.
    Ms Kathryn Maree Parsons Non-Executive Director May 2020
    Ms Parsons is currently a Non-Executive Director of Nick Scali Limited and Shape Australia Corporation Limited. She has knowledge of accounting, finance, governance and risk management. Formerly an audit partner at Ernst & Young she worked in the firm's US, UK and Australian practices. In addition to her audit client responsibilities, she was part of the firm's Oceania Assurance Leadership team as the Professional Practice Director with responsibility for assurance quality and risk management in the region. She is Chair of the Risk and Compliance Committee and Member of the People and Culture Committee.
    Ms Michelle Siekierka General CounselCompany Secretary Oct 2025
    -
    Michelle Siekierka General CounselCompany Secretary
    -
    Mr P. Varro Group Chief Financial Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Aust) Ltd 16,009,568 22.99%
    Citicorp Nominees Pty Limited 7,245,450 10.40%
    Chessari Holdings Pty Ltd 6,050,941 8.69%
    J P Morgan Nominees Australia Pty Limited 5,611,150 8.06%
    Asia Pac Technology Pty Ltd 3,068,025 4.41%
    Ubs Nominees Pty Ltd 1,377,875 1.98%
    Ann Leslie Ryan 1,008,418 1.45%
    BNP Paribas Norns Pty Ltd 569,534 0.82%
    Mohl Invest Pty Ltd <Mohl Super Fund A/C> 560,000 0.80%
    Warbont Nominees Pty Ltd cUnpaid Entrepot A/C> 476,686 0.68%
    National Nominees Limited 423,892 0.61%
    HSBC Custody Nominees (Australia) Limited 362,176 0.52%
    Tarrina Holdings Pty Ltd cTarrina Holding S/F A/C> 349,777 0.50%
    BNP Paribas Nominees Pty Ltd <Agency Lending A/C> 294,721 0.42%
    BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 216,352 0.31%
    Mestjo Pty Ltd 214,790 0.31%
    Mod Enterprises Pty Ltd 193,139 0.28%
    Birdseye No2 Management Pty Ltd <Birdseye Super No2 Fund A/C> 160,000 0.23%
    Isnf (Kn) Investments Pty Ltd clsnf Investments A/C> 155,983 0.22%
    Tn Terrigal Pty Ltd <Tn Terrigal A/C> 155,983 0.22%

    Profile

    since

    Note